Two-year persistence with teriparatide improved significantly after introduction of an educational and motivational support program
ConclusionThe introduction of the EMSP has demonstrated to improve the persistence with TPTD, resulting in 78% of the patients being persistent with TPTD during the 2-year treatment period.
Source: Osteoporosis International - Category: Orthopaedics Source Type: research
More News: Education | Forteo | Netherlands Health | Orthopaedics | Osteoporosis | Statistics | Study